Browse Results

  • Division: : Cancer Center


There are 190 clinical trial(s) matching your criteria.

Back

“A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Ramucirumab plus Docetaxel Versus Placebo plus Docetaxel in Patients with Locally Advanced or Unresectable or Metastatic Urothelial Carcinoma Who Progressed on or After Platinum Based Therapy”.

Investigator: Rakesh Singal

Institutional Protocol #: 20150428

National Clinical Trials Identifier: NCT02426125

Division: Cancer Center

Therapeutic Area: Prostate, Bladder, and Kidney Cancers

Phase: Phase III

Enrolling Since: 5/19/2016

A 1-Year Multicenter, Randomized, Open-Label Controlled Study to Evaluate the Efficacy and Safety of Umbilical Cord Blood Cells Expanded Ex Vivo with Mesenchymal Precursor Cells for Hematopoietic Recovery in Patients With Hematologic Malignancies After Myeloablative Conditioning

Investigator: Denise Pereira

Institutional Protocol #: 20140789

National Clinical Trials Identifier: NCT01854567

Division: Cancer Center

Therapeutic Area: Leukemia, Lymphoma, and Myeloma

Phase: Phase III

Enrolling Since: 9/10/2015

Transplant Registry Reporting

Investigator: Martin Andreansky

Institutional Protocol #: 20057012

National Clinical Trials Identifier: N/A

Division: Cancer Center

Therapeutic Area: Leukemia, Lymphoma, and Myeloma

Phase: N/A

Enrolling Since: 8/20/2012

Thyroid cancer and MMPs

Investigator: Sharon Elliot

Institutional Protocol #: 20057541

National Clinical Trials Identifier: N/A

Division: Cancer Center

Therapeutic Area: Thyroid and Other Endocrine Cancers

Phase: N/A

Enrolling Since: 6/24/2008

Back